Authors:
Lacombe ML; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France., Lamarche F; Université Grenoble Alpes, INSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), and SFR Environmental and Systems Biology (BEeSy), Grenoble, France., De Wever O; Laboratory of Experimental Cancer Research, Department of Human Structure and Repair, Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium., Padilla-Benavides T; Molecular Biology and Biochemistry Department, Wesleyan University, Middletown, USA., Carlson A; Molecular Biology and Biochemistry Department, Wesleyan University, Middletown, USA., Khan I; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA., Huna A; Cancer Research Center of Lyon, INSERM U1052, CNRS UMR 5286, Léon Bérard Center, Lyon University, Lyon, France., Vacher S; Unit of Pharmacogenetics, Department of Genetics, Curie Institute, Paris, France., Calmel C; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France., Desbourdes C; Université Grenoble Alpes, INSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), and SFR Environmental and Systems Biology (BEeSy), Grenoble, France., Cottet-Rousselle C; Université Grenoble Alpes, INSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), and SFR Environmental and Systems Biology (BEeSy), Grenoble, France., Hininger-Favier I; Université Grenoble Alpes, INSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), and SFR Environmental and Systems Biology (BEeSy), Grenoble, France., Attia S; Université Grenoble Alpes, INSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), and SFR Environmental and Systems Biology (BEeSy), Grenoble, France., Nawrocki-Raby B; Reims Champagne Ardenne University, INSERM, P3Cell UMR-S 1250, SFR CAP-SANTE, Reims, France., Raingeaud J; INSERM U1279, Gustave Roussy Institute, Villejuif, France., Machon C; Cancer Research Center of Lyon, INSERM U1052, CNRS UMR 5286, Léon Bérard Center, Lyon University, Lyon, France., Guitton J; Cancer Research Center of Lyon, INSERM U1052, CNRS UMR 5286, Léon Bérard Center, Lyon University, Lyon, France., Le Gall M; Proteomics Platform 3P5, Paris University, Cochin Institute, INSERM, U1016, CNRS, UMR8104, Paris, France., Clary G; Proteomics Platform 3P5, Paris University, Cochin Institute, INSERM, U1016, CNRS, UMR8104, Paris, France., Broussard C; Proteomics Platform 3P5, Paris University, Cochin Institute, INSERM, U1016, CNRS, UMR8104, Paris, France., Chafey P; Proteomics Platform 3P5, Paris University, Cochin Institute, INSERM, U1016, CNRS, UMR8104, Paris, France., Thérond P; AP-HP, CHU Bicêtre, Laboratory of Biochemistry, Le Kremlin-Bicêtre Hospital, Le Kremlin-Bicêtre, France.; EA7537, Paris Saclay University, Châtenay-Malabry, France., Bernard D; Cancer Research Center of Lyon, INSERM U1052, CNRS UMR 5286, Léon Bérard Center, Lyon University, Lyon, France., Fontaine E; Université Grenoble Alpes, INSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), and SFR Environmental and Systems Biology (BEeSy), Grenoble, France., Tokarska-Schlattner M; Université Grenoble Alpes, INSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), and SFR Environmental and Systems Biology (BEeSy), Grenoble, France., Steeg P; Women's Malignancies Branch, Center for Cancer Research, National Cancer Institute, Bethesda, USA., Bièche I; Unit of Pharmacogenetics, Department of Genetics, Curie Institute, Paris, France., Schlattner U; Université Grenoble Alpes, INSERM U1055, Laboratory of Fundamental and Applied Bioenergetics (LBFA), Institut Universitaire de France (IUF), Grenoble, France. uwe.schlattner@univ-grenoble-alpes.fr., Boissan M; Sorbonne Université, Inserm, Centre de Recherche Saint-Antoine, CRSA, Paris, France. mathieu.boissan@inserm.fr.; AP-HP, Laboratory of Biochemistry and Hormonology, Tenon Hospital, Paris, France. mathieu.boissan@inserm.fr.